A new agent active in the treatment of acute myeloblastic leukemia 22 050 RP

Recent Results Cancer Res. 1973:43:155-9. doi: 10.1007/978-3-642-80776-3_26.
No abstract available

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Child
  • Child, Preschool
  • Daunorubicin / adverse effects
  • Daunorubicin / analogs & derivatives*
  • Daunorubicin / therapeutic use*
  • Drug Evaluation
  • Female
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Male
  • Middle Aged
  • Remission, Spontaneous

Substances

  • Daunorubicin